LOC728640 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.603400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.131000E-01
Normal-vs-Stage2
2.567400E-01
Normal-vs-Stage3
7.221500E-03
Normal-vs-Stage4
8.034200E-01
Stage1-vs-Stage2
5.595000E-01
Stage1-vs-Stage3
6.768200E-02
Stage1-vs-Stage4
3.744200E-01
Stage2-vs-Stage3
1.117590E-01
Stage2-vs-Stage4
9.994400E-02
Stage3-vs-Stage4
2.314200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.701200E-01
Normal-vs-AfricanAmerican
3.842400E-01
Normal-vs-Asian
1.493990E-01
Caucasian-vs-AfricanAmerican
9.331400E-01
Caucasian-vs-Asian
3.484400E-01
AfricanAmerican-vs-Asian
6.351000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.115400E-01
Normal-vs-Female
3.399800E-01
Male-vs-Female
4.392200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.381800E-01
Normal-vs-Age(41-60Yrs)
6.311400E-01
Normal-vs-Age(61-80Yrs)
1.429410E-01
Normal-vs-Age(81-100Yrs)
9.831900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.981200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.806600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.918200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.676200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.278300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.537600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.244400E-02
Normal-vs-Daily Drinker
3.966100E-02
Normal-vs-Weekly Drinker
3.751400E-01
Normal-vs-Occasional Drinker
2.319000E-01
Normal-vs-Social Drinker
7.172600E-01
Non Drinker-vs-Daily Drinker
5.100800E-01
Non Drinker-vs-Weekly Drinker
3.012800E-01
Non Drinker-vs-Occasional Drinker
2.401200E-01
Non Drinker-vs-Social Drinker
1.033970E-02
Daily Drinker-vs-Weekly Drinker
1.416770E-01
Daily Drinker-vs-Occasional Drinker
1.309650E-01
Daily Drinker-vs-Social Drinker
9.018400E-03
Weekly Drinker-vs-Occasional Drinker
8.613400E-01
Weekly Drinker-vs-Social Drinker
3.588200E-01
Occasional Drinker-vs-Social Drinker
2.092800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.557600E-01
Normal-vs-Grade 2
4.335200E-01
Normal-vs-Grade 3
3.973600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.128600E-01
Grade 1-vs-Grade 3
4.438800E-01
Grade 1-vs-Grade 4
5.557600E-01
Grade 2-vs-Grade 3
6.711400E-01
Grade 2-vs-Grade 4
4.335200E-01
Grade 3-vs-Grade 4
3.973600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.104200E-02
Normal-vs-NonDiabetic
2.172800E-01
Diabetic-vs-NonDiabetic
1.088360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.256760E-01
Normal-vs-NoPancreatitis
1.834420E-01
Pancreatitis-vs-NoPancreatitis
6.292000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.298600E-01
Normal-vs-N1
2.416200E-01
N0-vs-N1
8.591600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.654400E-01
Normal-vs-TP53-NonMutant
7.145200E-01
TP53-Mutant-vs-TP53-NonMutant
8.229000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
